Some stupid kid with a computer that think's he's something, or just another paid basher working out of the hedge fund broom closet with big $dreams. Get a life loser!
I need this stock to slow down, below $25 on Friday please, then squeeze. I hate buying calls back, but love when they finish close to the $$$.
no, I think shorts are trying to get our hopes up before the cc, so they can crush hope and JL during the call...
they do have a lot of cash, but AP/payables is also very high. I was looking at the BS recently and wondering about payables, can anyone explain why so high? Also, I think book may be overstated, but I would be very happy with $4-5 since I have a nice position in the mid $2's.
I also bought BBEP a POS stock in terms of performance compared to GTE. Must be debt vs no debt and brent vs WTI that's making the difference. BBEP is very hedged at high prices...
Most firms won't pay more than a 100% premium no matter what a firm is "worth". So, unless ARNA rallies on some significant new clinical developments, at the current stock price, it's unlikely anyone will offer more then $9. I could also see the potential for a company to buy Belviq and spin out, or do something creative with the pipeline. It might take a failure in the pipeline to force Jack to sell, he seems content to continue soaking and diluting the shareholders.
Nice, Jeff was negative before the first FDA turn down, then went positive before the second try and approval. The analyst Wei turned bullish based on Bel-phen potential, which has not yet materialized, but overall they seem to be the most accurate firm covering the company.
Checking the chart, it appears EXAS has tested and retested the lows successfully and is now poised to test first resistance in the low $24's. If successful, a rapid move to around $26 is very possible (just not until after next Friday I hope).
very reasonable. As for Anthony, I doubt Eisai can just sell off their rights to another firm without ARNA's approval. I do think it's very possible a split is coming, or maybe they just don't want to make the investment in commercial until the market can be broadened and as stated, that will take more time and investment.
what are shorts going to do, cover, or stay put? I thought this would be a big down open followed by covering. I was expecting max volatility??? Nice of them to throw the LAR bone.
Eisai, let our people go to pursue max shareholder value or we will send plagues!
I would like to know what ARNA execs plan to do regarding Eisai and Belviq. Clearly this relationship is not working out for ARNA and Eiasi should allow ARNA to pursue all options including a new partnership, sale, etc. Eisai is not a good marketing partner, Jack made a big mistake and should be held accountable.
the only problem with low volume is that is allows for the shorts to play games. It also makes covering impossible without a very lager gain in the absence of a negative event. Maybe today was the turning point!
Junius just sold some options/shares that were about to retire. Glad Dan is still making money on this POS stock (not really, following and investing in the garbage while other better run companies were exploding in price was a big waste of my time and $).
I am waiting on access and reimb for cologuard. I called Cigna again today after receiving some promotional stuff in the main about getting FIT or colon or sigmoid for free. Cigna is still not covering it for now, when they do I will be first in line. I am a bit annoyed that I don't get reimbursement NOW!
yes, I was just about to mention BG M&A this should get the sector moving in a positive direction. 50% premium for a large co, there's probably a lot more in some of these smaller stocks that have dropped 75%-80% in price. Wit no debt, it's an easy bolt on.